IL22 and Alzheimer disease: Pso and AD could potentially have an immunological intersection: similarly to Pso, the Th1, Th17, and Th22 pathways, as well as IL-36 receptor signaling, are frequently activated in AD, resulting in elevated cutaneous levels of IL-22, IFN-γ, IL-36, and IL-17.